|
Basal cell carcinoma
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
|
Frontal fibrosing alopecia
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
|
30850646 |
2019 |
|
Basal Cell Cancer
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
|
Respiratory Tract Diseases
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Basal Cell Neoplasm
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
|
31174203 |
2019 |
|
Postmenopausal frontal fibrosing alopecia
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
|
30850646 |
2019 |
|
Endometrial Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis suggests that Leu432Val polymorphism is associated with ovarian cancer, lung cancer, and endometrial cancer risk; Asn453Ser and Arg48Gly polymorphisms are associated with endometrial cancer risk among Caucasians, Ala119Ser polymorphism is associated with prostate cancer risk, and Ala119Ser polymorphism is associated with breast cancer risk in Caucasians.
|
25475389 |
2015 |
|
Malignant neoplasm of endometrium
|
|
0.050 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis suggests that Leu432Val polymorphism is associated with ovarian cancer, lung cancer, and endometrial cancer risk; Asn453Ser and Arg48Gly polymorphisms are associated with endometrial cancer risk among Caucasians, Ala119Ser polymorphism is associated with prostate cancer risk, and Ala119Ser polymorphism is associated with breast cancer risk in Caucasians.
|
25475389 |
2015 |
|
Endometrial Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
CYP1B1 Leu432Val and Asn453Ser polymorphisms demonstrated an increased and decreased risk for endometrial cancer, respectively.
|
23370603 |
2013 |
|
Malignant neoplasm of endometrium
|
|
0.050 |
GeneticVariation
|
BEFREE |
CYP1B1 Leu432Val and Asn453Ser polymorphisms demonstrated an increased and decreased risk for endometrial cancer, respectively.
|
23370603 |
2013 |
|
Endometrial Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
In conclusion, this meta-analysis provides strong evidence that CYP1B1 gene R48G, L432V, and N4</span>53S polymorphisms are associated with endometrial cancer risk, but not A119S.
|
21191305 |
2011 |
|
Malignant neoplasm of endometrium
|
|
0.050 |
GeneticVariation
|
BEFREE |
In conclusion, this meta-analysis provides strong evidence that CYP1B1 gene R48G, L432V, and N4</span>53S polymorphisms are associated with endometrial cancer risk, but not A119S.
|
21191305 |
2011 |
|
Endometrial Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
The GSTM1 deletion and the variant (GG) genotype of the CYP1B1 rs1800440 polymorphism were associated with a decreased risk of developing endometrial cancer.
|
20381444 |
2010 |
|
Malignant neoplasm of endometrium
|
|
0.050 |
GeneticVariation
|
BEFREE |
The GSTM1 deletion and the variant (GG) genotype of the CYP1B1 rs1800440 polymorphism were associated with a decreased risk of developing endometrial cancer.
|
20381444 |
2010 |
|
Malignant neoplasm of endometrium
|
|
0.050 |
GeneticVariation
|
BEFREE |
We evaluated the association between the CYP1B1 Leu432Val and CYP1B1 Asn453Ser polymorphisms and the COMT Val158Met polymorphism and invasive endometrial cancer risk in a case-control study nested within the Nurses' Health Study (n = 222 cases, 666 controls).
|
14656940 |
2004 |
|
Endometrial Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
We evaluated the association between the CYP1B1 Leu432Val and CYP1B1 Asn453Ser polymorphisms and the COMT Val158Met polymorphism and invasive endometrial cancer risk in a case-control study nested within the Nurses' Health Study (n = 222 cases, 666 controls).
|
14656940 |
2004 |
|
Breast Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis suggests that Leu432Val polymorphism is associated with ovarian cancer, lung cancer, and endometrial cancer risk; Asn453Ser and Arg48Gly polymorphisms are associated with endometrial cancer risk among Caucasians, Ala119Ser polymorphism is associated with prostate cancer risk, and Ala119Ser polymorphism is associated with breast cancer risk in Caucasians.
|
25475389 |
2015 |
|
Malignant neoplasm of breast
|
|
0.040 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis suggests that Leu432Val polymorphism is associated with ovarian cancer, lung cancer, and endometrial cancer risk; Asn453Ser and Arg48Gly polymorphisms are associated with endometrial cancer risk among Caucasians, Ala119Ser polymorphism is associated with prostate cancer risk, and Ala119Ser polymorphism is associated with breast cancer risk in Caucasians.
|
25475389 |
2015 |
|
Malignant neoplasm of prostate
|
|
0.040 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis suggests that Leu432Val polymorphism is associated with ovarian cancer, lung cancer, and endometrial cancer risk; Asn453Ser and Arg48Gly polymorphisms are associated with endometrial cancer risk among Caucasians, Ala119Ser polymorphism is associated with prostate cancer risk, and Ala119Ser polymorphism is associated with breast cancer risk in Caucasians.
|
25475389 |
2015 |
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis suggests that Leu432Val polymorphism is associated with ovarian cancer, lung cancer, and endometrial cancer risk; Asn453Ser and Arg48Gly polymorphisms are associated with endometrial cancer risk among Caucasians, Ala119Ser polymorphism is associated with prostate cancer risk, and Ala119Ser polymorphism is associated with breast cancer risk in Caucasians.
|
25475389 |
2015 |
|
Malignant neoplasm of prostate
|
|
0.040 |
GeneticVariation
|
BEFREE |
According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.
|
24682418 |
2014 |
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.
|
24682418 |
2014 |
|
Prostate carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
The results suggest that L432V, N453S, and A119S polymorphisms of CYP1B1 might be associated with the susceptibility of PCa.
|
23861929 |
2013 |
|
Malignant neoplasm of prostate
|
|
0.040 |
GeneticVariation
|
BEFREE |
The results suggest that L432V, N453S, and A119S polymorphisms of CYP1B1 might be associated with the susceptibility of PCa.
|
23861929 |
2013 |
|
Malignant neoplasm of breast
|
|
0.040 |
GeneticVariation
|
BEFREE |
We detected SNP-HT interactions in women overall within CYP1B1 (rs1800440; p (het) = 0.003) and within CYP17A1 (rs743572; p (het) = 0.009) in which never users of HT were at a decreased risk of breast cancer, while ever users were at a non-significant increased risk.
|
22418777 |
2012 |